$ARWR ARROWHEAD PHARMACEUTICALS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ARROWHEAD PHARMACEUTICALS, INC. for free.
IRS Number: 460408024
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ARWR
Company Address: 177 E COLORADO BLVD SUITE 700 PASADENA 91105
Phone number: 626-304-3400
Former name: INTERACTIVE INC, date of change: 1994-02-24
Former name: INTERACTIVE INC, date of change: 1994-02-24
Former name: INTERACTIVE GROUP INC, date of change: 2002-05-09
Former name: ARROWHEAD RESEARCH CORP, date of change: 2004-01-12
Market Capitalization: $149.83M
Prev close: $1.96
Average Daily Volume: 2,180,680
Days Low: $1.91
Year Low: $1.20
Year High: $8.22
ARROWHEAD PHARMACEUTICALS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 89.21 | 4,500 | 401,445 | 114,868 | 119.4 K to 114.9 K (-3.77 %) |
| Feb 24 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 88.73 | 1,125 | 99,821 | 13,875 | 15 K to 13.9 K (-7.50 %) |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Option Exercise | M | 5.22 | 90,000 | 469,800 | 60,000 | |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 89.66 | 5,436 | 487,392 | 293,375 | 298.8 K to 293.4 K (-1.82 %) |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 88.88 | 45,348 | 4,030,530 | 298,811 | 344.2 K to 298.8 K (-13.18 %) |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 88.08 | 31,255 | 2,752,940 | 344,159 | 375.4 K to 344.2 K (-8.33 %) |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 86.72 | 7,961 | 690,378 | 375,414 | 383.4 K to 375.4 K (-2.08 %) |
| Feb 10 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Buy | M | 5.22 | 90,000 | 469,800 | 383,375 | 293.4 K to 383.4 K (+30.68 %) |
| Jan 19 2021 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 83.28 | 3,000 | 249,840 | 12,500 | 15.5 K to 12.5 K (-19.35 %) |
| Jan 15 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 81.82 | 3,814 | 312,061 | 126,250 | 130.1 K to 126.3 K (-2.93 %) | |
| Jan 15 2021 | ARWR | ARROWHEAD PHARMACE ... | Hamilton James C | Sell | S | 80.97 | 6,186 | 500,880 | 130,064 | 136.3 K to 130.1 K (-4.54 %) | |
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.00 | 1,441 | 116,721 | 444,005 | 445.4 K to 444 K (-0.32 %) |
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.02 | 11,597 | 939,589 | 445,446 | 457 K to 445.4 K (-2.54 %) |
| Jan 08 2021 | ARWR | ARROWHEAD PHARMACE ... | Hassard James | Chief Commercial Of ... | Sell | S | 75.00 | 15,625 | 1,171,875 | 109,375 | 125 K to 109.4 K (-12.50 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 72.67 | 13,243 | 962,369 | 293,375 | 306.6 K to 293.4 K (-4.32 %) |
View all ARROWHEAD PHARMACEUTICALS, INC. insider transactions.